🔍 Observations
Topline
- Revenue from operations surged to ₹36,264 Mn in FY26 vs ₹27,218 Mn in FY25 — a 33.2% YoY jump, with Q4 FY26 alone clocking ₹12,426 Mn (26.3% of full-year revenue), signalling accelerating execution.
- Q4 FY26 revenue grew 26.2% YoY (₹9,845 Mn → ₹12,426 Mn) and 54.6% QoQ (₹8,040 Mn → ₹12,426 Mn), reflecting strong order deliveries in the quarter.
- Other income of ₹1,568 Mn (FY26) vs ₹1,070 Mn (FY25) includes interest income of ₹1,011 Mn — notable, but the core revenue growth dominates the narrative.
Bottomline
- Net profit grew 24.0% YoY — ₹3,639 Mn in FY26 vs ₹2,934 Mn in FY25 — lagging revenue growth due to elevated depreciation and a provision for doubtful debts of ₹782 Mn.
- Q4 FY26 net profit of ₹912 Mn fell 21.5% YoY vs ₹1,162 Mn in Q4 FY25, driven by sharply higher D&A (₹544 Mn vs ₹169 Mn YoY) as new capex gets commissioned.
- Basic EPS rose to ₹54.85 (FY26) from ₹45.82 (FY25), a 19.7% increase, slightly diluted by QIP-driven equity expansion.
Margins
- EBITDA proxy (PBT before exceptional + D&A + Finance cost): ₹5,069 + ₹1,071 + ₹1,169 = ₹7,309 Mn on revenue of ₹36,264 Mn — EBITDA margin ~20.2% (FY25: ₹3,716 + ₹447 + ₹1,013 = ₹5,176 Mn on ₹27,218 Mn = 19.0%). Margin expansion of ~120 bps YoY.
- Net profit margin compressed slightly: 10.0% (₹3,639/₹36,264) vs 10.8% (₹2,934/₹27,218) — the ₹782 Mn doubtful debt provision is the primary drag.
- Material cost as % of revenue: ₹25,422 Mn / ₹36,264 Mn = 70.1% (FY25: ₹19,116 / ₹27,218 = 70.2%) — stable input cost structure despite scale-up.
Growth Trajectory
- 3-year CAGR is not computable from provided data, but FY26 marks the second consecutive year of ~30%+ revenue growth — a pattern consistent with strong order book execution in EMS.
- Employee costs nearly doubled YoY (₹3,136 Mn vs ₹1,781 Mn), reflecting capacity and capability build for higher-complexity segments — dilutive near-term but value-accretive structurally.
- D&A nearly tripled YoY (₹1,071 Mn vs ₹447 Mn), confirming aggressive asset commissioning; earnings growth will re-accelerate as utilisation improves.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- 33.2% revenue CAGR-like growth in FY26 proves order execution momentum is real, not pulled forward.
- EBITDA margin expansion of ~120 bps (19.0% → 20.2%) despite rapid headcount and infrastructure build signals operating leverage kicking in.
- QIP proceeds of ~₹16,015 Mn injected in FY26 materially strengthened equity (₹47,625 Mn vs ₹28,442 Mn), eliminating near-term balance sheet stress.
- Short-term borrowings cut by ₹2,701 Mn (₹8,080 Mn → ₹5,379 Mn) post-QIP — improving debt quality and reducing refinancing risk.
- Material cost ratio stable at 70.1% despite rapid scale-up — indicates pricing discipline and procurement efficiency.
- Intangible asset base doubled (₹1,329 Mn → ₹3,820 Mn), reflecting deepening IP investment in higher-margin design-led EMS.
- Q4 FY26 sequential revenue jump of 54.6% — strongest quarter on record — signals accelerating delivery cadence heading into FY27.
🔴 Red Flags
- Negative operating cash flow of ₹(6,004) Mn in FY26 vs ₹(823) Mn in FY25 — cash is being consumed faster than profits are generated; unsustainable without continued equity raises.
- Trade receivables ballooned to ₹15,276 Mn from ₹5,746 Mn (FY25) — a ₹9,530 Mn YoY surge, more than double revenue growth; collection risk is material.
- Doubtful debt provision of ₹782 Mn in FY26 vs ₹194 Mn in FY25 — early signal that some receivables are impaired; bears close monitoring.
- Capex of ₹12,403 Mn in FY26 with no free cash flow generation — the company is in heavy investment mode; equity-funded today, but future debt servicing capacity hinges on utilisation ramp.
- Q4 FY26 net profit declined 21.5% YoY despite 26% revenue growth — the D&A overhang from new assets will continue to weigh on PAT until facilities are fully loaded.
- Employee cost almost doubled (₹1,781 Mn → ₹3,136 Mn) — rapid talent acquisition inflates the fixed cost base, increasing operating leverage risk in a revenue slowdown scenario.
- Non-current borrowings rose 4x (₹675 Mn → ₹3,370 Mn) — while manageable given the equity cushion, long-term debt trajectory warrants watching.
📊 Balance Sheet Analysis
- Equity-heavy post-QIP: Total equity of ₹47,625 Mn vs total debt (short + long-term borrowings) of ₹8,749 Mn — debt-to-equity of ~0.18x. Strong solvency; low near-term financial distress risk.
- Asset quality concern: Trade receivables of ₹15,276 Mn represent 42.1% of FY26 revenue — an abnormally high receivable days. Alongside the ₹782 Mn doubtful debt provision, this is the single biggest balance sheet risk.
- Capex in progress: PPE nearly doubled (₹5,045 Mn → ₹11,097 Mn) and CWIP stands at ₹3,724 Mn — indicates substantial capacity under commissioning that should drive future revenue.
- Current ratio: Current assets ₹38,473 Mn / Current liabilities ₹17,273 Mn = 2.23x — healthy liquidity; well-covered even after adjusting for slow receivables.
💰 Cash Flow Analysis
- Operating cash flow of ₹(6,004) Mn is driven by the ₹10,239 Mn surge in trade receivables — profit generation is sound (₹5,043 Mn PBT), but working capital expansion is consuming all cash.
- Investing outflow of ₹(9,172) Mn reflects ₹12,403 Mn in fixed asset purchases, partially offset by ₹3,197 Mn FD redemptions — the company is in peak capex cycle.
- Financing inflow of ₹15,796 Mn is almost entirely the QIP (₹16,015 Mn in equity proceeds) — this is a one-time lever; operational self-funding is still not achieved.
- Net cash position improved to ₹1,094 Mn from ₹474 Mn — but this understates liquidity since ₹6,892 Mn sits in other bank balances (FDs), giving total liquid holdings of ~₹7,986 Mn.
💡 Investment Outlook
Kaynes is executing a classic high-growth EMS scale-up: revenue compounding at 30%+, margins expanding, and an equity-funded capex cycle building capacity ahead of demand.
The near-term PAT growth will remain suppressed by D&A from newly commissioned assets and elevated employee costs — but these are growth investments, not structural inefficiencies.
The critical variable to monitor is trade receivables: at 42% of revenue with a growing doubtful debt provision, any customer-level payment stress could materially impair cash generation.
As asset utilisation improves and receivables normalise, the margin inflection required for re-rating should materialise — but the timeline is FY27–28, not immediate.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.